REFERENCES
- Amendola L., Molaioni F., Botre F. Detection of beta-blockers in human urine by GC-MS-MS-EI: Perspectives for the antidoping control. J. Pharm. Biomed. Anal 2000; 23(1)211–221, [INFOTRIEVE], [CSA]
- Hemmersbach P., de la Torre R. Stimulants, narcotics and β-blockers: 25 years of development in analytical techniques for doping control. J. Chromatogr. B 1996; 687: 221–238, [CSA]
- Kintz P., Dumestre-Toulet V., Jamey C., Cirimele V., Ludes B. Doping control of beta-adrenergic compounds through hair analysis. J. Forensic. Sci 2000; 45(1)170–4, [INFOTRIEVE], [CSA]
- Drayer D.E. Lipophilicity, hydrophilicity, and the central nervous system side effects of beta blockers. Pharmacotherapy 1987; 7(4)87–91, [INFOTRIEVE], [CSA]
- Drayer D.E. Clinical consequences of the lipophilicity and plasma protein binding of antiarrhytmic drugs and active metabolites in. man. Ann. NY Acad. Sci 1984; 432: 45–56, [CSA]
- Hjalmarson A. Cardioprotection with beta-adrenoceptor blockers. Does lipophilicity matter?. Basic Res. Cardiol 2000; 95: 141–145, [CSA]
- Tetko I.V., Tanchuk V.Y., Kasheva T.N., Villa A.E. Internet software for the calculation of the lipophilicity and aqueous solubility of chemical compounds. J. Chem. Inf. Comput. Sci 2001; 41(2)246–252, [INFOTRIEVE], [CSA], [CROSSREF]
- Arendt R.M., Greenblatt D.J. Liquid chromatographic retention of beta-adrenoceptor antagonists: an index of lipid solubility. J. Pharm. Pharmacol 1984; 36(6)400–401, [INFOTRIEVE], [CSA]
- Detroyer A., Vander Heyden Y., Carda-Broch S., Garcia-Alvarez-Coque M.C., Massart D.L. Quantitative structure-retention and retention-activity relationships of blocking agents by micellar liquid chromatography. J. Chromatogr A 2001; 912(2)211–221, [INFOTRIEVE], [CSA], [CROSSREF]
- Gonzales A.G., Herrador M.A., Asuero A.G. Hydrophobicity of β-adrenoceptor blocking agents: Study of correlations between retention in reversed-phase HPLC systems and octanol-water partition constants. Int. J. Pharm 1995; 120: 215–220, [CSA], [CROSSREF]
- Gulyaeva N., Zaslavsky A., Lechner P., Chlenov M., Chait A., Zaslavsky B. Relative hydrophobicity and lipophilicity of beta-blockers and related compounds as measured by aqueous two-phase partitioning, octanol-buffer partitioning and HPLC. Eur. J. Pharm. Sci. 2002; 17(1/2)81–93, [INFOTRIEVE], [CSA], [CROSSREF]
- Martinez V., Maguregui M.I., Jimenez R.M., Alonzo R.M. Determination of the pKa values of beta-blockers by automated potentiometric titrations. J. Pharm. Biomed. Anal 2000; 23: 459–468, [INFOTRIEVE], [CSA], [CROSSREF]
- Zhao Y., Jona J., Chow D.T., Rong H., Semin D., Xia X., Zanon R., Spancake C., Maliski E. High-throughput logP measurement using parallel liquid chromatography/ultraviolet/mass spectrometry and sample-pooling. Rapid Commun. Mass Spectrom 2002; 16(16)1548–1555, [INFOTRIEVE], [CSA], [CROSSREF]
- Andrisano V., Gotti R., Leoni A., Cavrini V. Photodegradation studies on atenolol by liquid chromatography. J. Pharm. Biomed. Anal 1999; 21: 851–857, [INFOTRIEVE], [CSA], [CROSSREF]
- Tuszyńska E., Kwiatkowska B., Wieczorkowska A., Kaniewska T. Investigation on chemical changes in overdue pharmaceuticals. Part I. Investigations on decomposition of atenolol. Chem. Anal 1994; 39: 563, [CSA]
- Marton S., Hatem A., Csoka G., Racz I. Preformulation study of atenolol-containing solutions I. The pH dependence of thermostability. Acta Pharm. Hung 2001; 71(2)192–195, [INFOTRIEVE], [CSA]
- Modamio P., Lastra C.F., Montejo O., Marino E.L. Development and validation of liquid chromatography methods for the quantitation of propranolol, metoprolol, atenolol and bisoprolol: Application in solution stability studies. Int. J. Pharm 1996; 130: 137–140, [CSA], [CROSSREF]
- El-Gindy A., Ashour A., Abel-Fattah L., Shabana M. First derivative spectrophotometric, TLC-densitometric, and HPLC determination of acebutolol HCl in presence of its acid-induced degradation product. J. Pharm. Biomed. Anal 2001; 24(4)527–534, [INFOTRIEVE], [CSA], [CROSSREF]
- Bartolomei M., Bertocchi P., Ramusino M.C., Santucci N., Valvo L. Physico-chemical characterisation of the modifications I and II of (R, S) propranolol hydrochloride: solubility and dissolution studies. J. Pharm. Biomed. Anal 1999; 21: 299–309, [INFOTRIEVE], [CSA], [CROSSREF]
- Constantinescu T., Popa E. Propranolol purity and quality control. Rev. Chim 1983; 34(6)548–553, [CSA]
- Henry D.W., Repta A.J., Smith F.M., White S.J. Stability of propranolol hydrochloride suspension compounded from tablets. Am. J. Hosp. Pharm 1986; 43(6)1492–1495, [INFOTRIEVE], [CSA]
- Krzek J., Kwiecień A. Application of densitometry for determination of beta-adrenergic-blocking agents in pharmaceutical preparations. J. Planar Chromatogr 2005; 18: 313–318, [CSA]
- Carda-Broch S., Berthod A. pH dependence of the hydrophobicity of β-blocker amine compounds measured by counter-current chromatography. J. Chromatogr. A 2002; 995: 55–66, [CSA], [CROSSREF]